Netrin-4 promotes glioblastoma cell proliferation through integrin β4 signaling

Neoplasia

Volumn 14, Issue 3, 2012, Pages 219-227

  Hu, Yizhou ^a   Ylivinkka, Irene ^a   Chen, Ping ^b   Li, Li ^a   Hautaniemi, Sampsa ^b   Nyman, Tuula A ^c   Keski Oja, Jorma ^a   Hyytiäinen, Marko ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; BROXURIDINE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NETRIN; NETRIN 4; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTE; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MITOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 84859112997     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.111396     Document Type: Article

References (52)

1. Cirulli V and Yebra M (2007). Netrins: beyond the brain. Nat Rev Mol Cell Biol 8, 296-306.
2. Hong K, Hinck L, Nishiyama M, Poo MM, Tessier-Lavigne M, and Stein E (1999). A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell 97, 927-941.
3. Larrivee B, Freitas C, Trombe M, Lv X, Delafarge B, Yuan L, Bouvree K, Breant C, Toro R, Brechot N, et al. (2007). Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev 21, 2433-2447.
4. Park KW, Crouse D, Lee M, Karnik SK, Sorensen LK, Murphy KJ, Kuo CJ, and Li DY (2004). The axonal attractant Netrin-1 is an angiogenic factor. Proc Natl Acad Sci USA 101, 16210-16215.
5. Wilson BD, Ii M, Park KW, Suli A, Sorensen LK, Larrieu-Lahargue F, Urness LD, Suh W, Asai J, Kock GA, et al. (2006). Netrins promote developmental and therapeutic angiogenesis. Science 313, 640-644.
6. Yang Y, Zou L, Wang Y, Xu KS, Zhang JX, and Zhang JH (2007). Axon guidance cue Netrin-1 has dual function in angiogenesis. Cancer Biol Ther 6, 743-748.
7. Srinivasan K, Strickland P, Valdes A, Shin GC, and Hinck L (2003). Netrin-1/ neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell 4, 371-382.
8. Liu Y, Stein E, Oliver T, Li Y, Brunken WJ, Koch M, Tessier-Lavigne M, and Hogan BL (2004). Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. Curr Biol 14, 897-905.
9. Yebra M, Montgomery AM, Diaferia GR, Kaido T, Silletti S, Perez B, Just ML, Hildbrand S, Hurford R, Florkiewicz E, et al. (2003). Recognition of the neural chemoattractant Netrin-1 by integrins α6β4 and α3β1 regulates epithelial cell adhesion and migration. Dev Cell 5, 695-707.
10. Mehlen P, Delloye-Bourgeois C, and Chedotal A (2011). Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nat Rev Cancer 11, 188-197.
11. Koch M, Murrell JR, Hunter DD, Olson PF, Jin W, Keene DR, Brunken WJ, and Burgeson RE (2000). A novel member of the netrin family, β-netrin, shares homology with the β chain of laminin: identification, expression, and functional characterization. J Cell Biol 151, 221-234.
12. Staquicini FI, Dias-Neto E, Li J, Snyder EY, Sidman RL, Pasqualini R, and Arap W (2009). Discovery of a functional protein complex of netrin-4, laminin γ1 chain, and integrin α6β1 in mouse neural stem cells. Proc Natl Acad Sci USA 106, 2903-2908.
13. Yin Y, Sanes JR, and Miner JH (2000). Identification and expression of mouse netrin-4. Mech Dev 96, 115-119.
14. Hoang S, Liauw J, Choi M, Guzman RG, and Steinberg GK (2009). Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab 29, 385-397.
15. Larrieu-Lahargue F, Welm AL, Thomas KR, and Li DY (2010). Netrin-4 induces lymphangiogenesis in vivo. Blood 115, 5418-5426.
16. Lejmi E, Leconte L, Pedron-Mazoyer S, Ropert S, Raoul W, Lavalette S, Bouras I, Feron JG, Maitre-Boube M, Assayag F, et al. (2008). Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B. Proc Natl Acad Sci USA 105, 12491-12496.
17. Schneiders FI, Maertens B, Bose K, Li Y, Brunken WJ, Paulsson M, Smyth N, and Koch M (2007). Binding of netrin-4 to laminin short arms regulates basement membrane assembly. J Biol Chem 282, 23750-23758.
18. Eveno C, Broqueres-You D, Feron JG, Rampanou A, Tijeras-Raballand A, Ropert S, Leconte L, Levy BI, and Pocard M (2011). Netrin-4 delays colorectal cancer carcinomatosis by inhibiting tumor angiogenesis. Am J Pathol 178(4), 1861-1869.
19. Nacht M, St Martin TB, Byrne A, Klinger KW, Teicher BA, Madden SL, and Jiang Y (2009). Netrin-4 regulates angiogenic responses and tumor cell growth. Exp Cell Res 315, 784-794.
20. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, and Berens ME (2005). Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7, 7-16.
21. Yuan Y, Leszczynska M, Konstantinovsky S, Trope CG, Reich R, and Davidson B (2011). Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors. Diagn Cytopathol 38(8), 562-566.
22. Yebra M, Diaferia GR, Montgomery AM, Kaido T, Brunken WJ, Koch M, Hardiman G, Crisa L, and Cirulli V (2011). Endothelium-derived Netrin-4 supports pancreatic epithelial cell adhesion and differentiation through integrins α2β1 and α3β1. PLoS One 6, e22750.
23. Larrieu-Lahargue F, Welm AL, Thomas KR, and Li DY (2011). Netrin-4 activates endothelial integrin α6β1. Circ Res 109, 770-774.
24. Takemoto M, Hattori Y, Zhao H, Sato H, Tamada A, Sasaki S, Nakajima K, and Yamamoto N (2011). Laminar and areal expression of Unc5d and its role in cortical cell survival. Cereb Cortex 21(8), 1925-1934.
25. Louis DN (2006). Molecular pathology of malignant gliomas. Annu Rev Pathol 1, 97-117.
26. Öhman T, Lietzen N, Välimäki E, Melchjorsen J, Matikainen S, and Nyman TA (2010). Cytosolic RNA recognition pathway activates 14-3-3 protein mediated signaling and caspase-dependent disruption of cytokeratin network in human keratinocytes. J Proteome Res 9, 1549-1564.
27. Chen P, Lepikhova T, Hu Y, Monni O, and Hautaniemi S (2011). Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants. Nucleic Acids Res 39(18), e123.
28. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, Aittomaki V, Valo E, Nunez-Fontarnau J, Rantanen V, Karinen S, et al. (2010). Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med 2, 65.
29. Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, and Giancotti FG (2006). β4 Integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126, 489-502.
30. Kawataki T, Yamane T, Naganuma H, Rousselle P, Anduren I, Tryggvason K, and Patarroyo M (2007). Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: evidence for a role of α5-laminin(s) and α3β1 integrin. Exp Cell Res 313, 3819-3831.
31. Belot N, Rorive S, Doyen I, Lefranc F, Bruyneel E, Dedecker R, Micik S, Brotchi J, Decaestecker C, Salmon I, et al. (2001). Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. Glia 36, 375-390.
32. Hata K, Kaibuchi K, Inagaki S, and Yamashita T (2009). Unc5B associates with LARG to mediate the action of repulsive guidance molecule. J Cell Biol 184, 737-750.
33. Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
34. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and geno- type of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403.
35. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9, 287-300.
36. Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, and Giancotti FG (2004). Integrin β4 signaling promotes tumor angiogenesis. Cancer Cell 6, 471-483.
37. Shaw LM (2001). Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the α6β4 integrin-dependent activation of phospho- inositide 3-OH kinase and promotion of invasion. Mol Cell Biol 21, 5082-5093.
38. Bon G, Folgiero V, Bossi G, Felicioni L, Marchetti A, Sacchi A, and Falcioni R (2006). Loss of β4 integrin subunit reduces the tumorigenicity of MCF7 mam- mary cells and causes apoptosis upon hormone deprivation. Clin Cancer Res 12, 3280-3287.
39. Chung J, Bachelder RE, Lipscomb EA, Shaw LM, and Mercurio AM (2002). Integrin (α6β4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 158, 165-174.
40. Shah OJ and Hunter T (2006). Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis. Mol Cell Biol 26, 6425-6434.
41. Shaw RJ and Cantley LC (2006). Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424-430.
42. Yang YH, Szabat M, Bragagnini C, Kott K, Helgason CD, Hoffman BG, and Johnson JD (2011). Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate β cell apoptosis signalling via dependence receptors. Diabetologia 54, 828-842.
43. Giancotti FG (2007). Targeting integrin β4 for cancer and anti-angiogenic therapy. Trends Pharmacol Sci 28, 506-511.
44. Previtali S, Quattrini A, Nemni R, Truci G, Ducati A, Wrabetz L, and Canal N (1996). α6β4 and α6β1 integrins in astrocytomas and other CNS tumors. J Neuropathol Exp Neurol 55, 456-465.
45. Shaw CE, Milner R, Compston AS, and ffrench-Constant C (1996). Analysis of integrin expression on oligodendrocytes during axo-glial interaction by using rat-mouse xenocultures. J Neurosci 16, 1163-1172.
46. Gambaletta D, Marchetti A, Benedetti L, Mercurio AM, Sacchi A, and Falcioni R (2000). Cooperative signaling between α6β4 integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem 275, 10604-10610.
47. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, and Giancotti FG (2001). EGF-R signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 155, 447-458.
48. Santoro MM, Gaudino G, and Marchisio PC (2003). The MSP receptor regulates α6β4 and α3β1 integrins via 14-3-3 proteins in keratinocyte migration. Dev Cell 5, 257-271.
49. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, and Toker A (2002). The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4, 540-544.
50. Lefranc F, Brotchi J, and Kiss R (2005). Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23, 2411-2422.
51. Nakamura JL, Garcia E, and Pieper RO (2008). S6K1 plays a key role in glial transformation. Cancer Res 68, 6516-6523.
52. Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, James CD, and Sarkaria JN (2005). Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells. Neoplasia 7, 921-929.